HBOT Conversations

HBOT Conversations Ep 2.1 | Dr. Peter Canaday (Part 1)

September 15, 2023 HBOT News Season 2 Episode 1
HBOT Conversations Ep 2.1 | Dr. Peter Canaday (Part 1)
HBOT Conversations
More Info
HBOT Conversations
HBOT Conversations Ep 2.1 | Dr. Peter Canaday (Part 1)
Sep 15, 2023 Season 2 Episode 1
HBOT News

In this episode of HBOT News Network Conversations, Dr. Peter Canaday, who has over 40 years of experience in medicine and Hyperbaric Oxygen Therapy (HBOT), shares insights into his medical background and history with HBOT.

Dr. Canaday discusses his early involvement with HBOT in the 1980s and provides listeners with a detailed overview of his medical journey and experiences. He also mentions the importance of recent research by Dr. Paul G. Harch, specifically referencing two articles related to HBOT's efficacy in treating mild traumatic brain injury and the epigenetic effects of oxygen and pressure.

The conversation then shifts to the topic of COVID-19. The host, Edward di Girolamo, discusses the challenges faced by long-hauler COVID patients and the increasing number of vaccine injuries associated with COVID-19 vaccines. Dr. Canaday acknowledges the suppression of scientific inquiry and information related to COVID-19 and its vaccines. He emphasizes that even data from peer-reviewed literature has been ignored or sidelined without discussion.

Dr. Canaday provides viewers with direct links to resources where they can learn more about the data and information he has shared regarding the COVID-19 vaccine rollouts. The conversation concludes with the announcement of a two-part series, with Part 2 scheduled to air later.

This HBOT News Conversation was filmed on October 4, 2022.

Show Notes

In this episode of HBOT News Network Conversations, Dr. Peter Canaday, who has over 40 years of experience in medicine and Hyperbaric Oxygen Therapy (HBOT), shares insights into his medical background and history with HBOT.

Dr. Canaday discusses his early involvement with HBOT in the 1980s and provides listeners with a detailed overview of his medical journey and experiences. He also mentions the importance of recent research by Dr. Paul G. Harch, specifically referencing two articles related to HBOT's efficacy in treating mild traumatic brain injury and the epigenetic effects of oxygen and pressure.

The conversation then shifts to the topic of COVID-19. The host, Edward di Girolamo, discusses the challenges faced by long-hauler COVID patients and the increasing number of vaccine injuries associated with COVID-19 vaccines. Dr. Canaday acknowledges the suppression of scientific inquiry and information related to COVID-19 and its vaccines. He emphasizes that even data from peer-reviewed literature has been ignored or sidelined without discussion.

Dr. Canaday provides viewers with direct links to resources where they can learn more about the data and information he has shared regarding the COVID-19 vaccine rollouts. The conversation concludes with the announcement of a two-part series, with Part 2 scheduled to air later.

This HBOT News Conversation was filmed on October 4, 2022.